IFNG and systemic lupus erythematosus: Treatment of triple congenic B6.Sle1.Sle2.Sle3 lupus-prone mice with metformin, the inhibitor of mitochondrial metabolism, corrected abnormal T cell metabolism, reduced IFNγ production and restored the IL-2 production [47].